Key Events This Week
Mar 30: Poly Medicure hits 52-week low at Rs.1,190.80
Apr 1: Opens with 5.05% gap up and surges 7.38% intraday
Apr 2: Continues rally, closing at Rs.1,336.30 (+4.31%)
Apr 3: No trading data available
30 March 2026: Stock Hits 52-Week Low Amid Market Weakness
Poly Medicure Ltd’s shares declined to a fresh 52-week low of Rs.1,190.80 on 30 March 2026, pressured by broad market weakness and sectoral headwinds. The stock fell 3.17% on the day, underperforming the Sensex which dropped 2.29%. This decline extended a recent downtrend, with the stock trading below all key moving averages, signalling sustained bearish momentum.
The Medical Equipment, Supplies, and Accessories segment also faced pressure, falling 2.06% on the same day. Poly Medicure’s one-year performance remains weak, down 46.06%, far below the Sensex’s 6.69% decline. Despite a profit growth of 11.9% over the past year, the stock’s valuation metrics such as a PEG ratio of 3 and price-to-book ratio of 4.3 suggest expensive pricing relative to earnings growth and book value.
Quarterly results revealed a 11.0% decline in profit after tax to Rs.75.86 crores for the December 2025 quarter, alongside contracting operating margins and slower debtor turnover, indicating operational challenges. Institutional investors maintain a 23.24% stake, reflecting some confidence despite the price weakness.
Just made the cut! This Mid Cap from the Heavy Electrical Equipment sector entered our elite Top 1% list recently. Discover it before the crowd catches on!
- - Top-rated across platform
- - Strong price momentum
- - Near-term growth potential
1 April 2026: Strong Gap Up and Intraday Rally Signal Rebound
On 1 April 2026, Poly Medicure Ltd reversed its recent losses with a robust 7.38% intraday surge, reaching a high of Rs.1,273.75. The stock opened with a notable 5.05% gap up at Rs.1,250.95, reflecting strong buying interest amid positive market sentiment. Despite some profit-taking, the stock closed up 7.58%, outperforming both its sector’s 6.74% gain and the Sensex’s 1.97% rise.
This rally marked a technical bounce after two days of decline, with the stock closing above its 5-day moving average but still below longer-term averages, indicating that the broader downtrend remains intact. Technical indicators presented a mixed picture: weekly RSI showed bullish tendencies, while MACD and Bollinger Bands remained bearish on weekly and monthly timeframes.
Poly Medicure’s small-cap status and beta of 1.35 relative to the NIFTY MIDCAP150 index contribute to its volatility, explaining the sharp price swings. The stock’s mojo grade improved from 'Strong Sell' to 'Sell' in February 2026, signalling a cautious but slightly less negative outlook.
2 April 2026: Continued Momentum Pushes Stock to Weekly High
The positive momentum extended into 2 April 2026, with Poly Medicure Ltd gaining an additional 4.31% to close at Rs.1,336.30, the highest price of the week. This advance further distanced the stock from its 52-week low and reinforced the short-term recovery narrative. The Sensex, by contrast, was largely flat with a marginal 0.08% gain, underscoring the stock’s relative strength.
Despite this rally, the stock remains below its 20-day and longer moving averages, suggesting that the recovery may be a technical correction rather than a sustained trend reversal. The healthcare sector’s resilience and the stock’s outperformance relative to the broader market highlight selective investor interest amid ongoing sectoral challenges.
Holding Poly Medicure Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Daily Price Comparison: Poly Medicure Ltd vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-03-30 | Rs.1,190.80 | -3.17% | 32,182.38 | -2.29% |
| 2026-04-01 | Rs.1,281.10 | +7.58% | 32,814.97 | +1.97% |
| 2026-04-02 | Rs.1,336.30 | +4.31% | 32,839.65 | +0.08% |
Key Takeaways from the Week
Positive Signals: Poly Medicure Ltd demonstrated a strong technical rebound after hitting a 52-week low, gaining 8.66% over the week and outperforming the Sensex by 8.95%. The gap up and intraday surge on 1 April highlighted renewed buying interest, supported by a modest improvement in mojo rating from 'Strong Sell' to 'Sell'. Institutional holdings remain significant at 23.24%, providing some stability.
Cautionary Notes: Despite the rally, the stock remains below all major moving averages except the 5-day, indicating the broader downtrend persists. Quarterly earnings showed a decline in profit and operating margins, while slower debtor turnover points to operational challenges. Technical indicators such as MACD and Bollinger Bands remain bearish on weekly and monthly timeframes, suggesting the recovery may be short-lived.
The stock’s proximity to its 52-week low and its classification as a small-cap with a beta of 1.35 imply continued volatility. Investors should weigh the recent price strength against the underlying fundamental and technical headwinds.
Conclusion
Poly Medicure Ltd’s week was marked by a significant turnaround from a 52-week low to a strong rally, closing the week at Rs.1,336.30 with an 8.66% gain. This performance outpaced the Sensex’s slight decline, reflecting selective investor optimism amid a challenging market environment. However, the stock’s position below key moving averages and mixed technical signals counsel caution. The recent gains may represent a technical bounce rather than a sustained recovery, with fundamental challenges still evident in earnings and operational metrics. Continued monitoring of price action and sector trends will be essential to assess the durability of this rebound.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
